NOW LET US – AI RAG SaaS Studio TP.HCM
NOW LET US
Digital Product Studio
Back to news
AGENTIC-SYSTEMS...1 min read

An AI agent for treatment reasoning over a biomedical tool universe

Share
NOW LET US Article – An AI agent for treatment reasoning over a biomedical tool universe

Researchers have introduced ATHENA-R1, a breakthrough AI agent capable of advanced treatment reasoning across all FDA-approved drugs since 1939. Trained via reinforcement learning over 212 biomedical tools, it outperforms leading models like GPT-5 in complex medical decision-making.

Computer Science > Artificial Intelligence

Title:An AI agent for treatment reasoning over a biomedical tool universe

View PDF HTML (experimental)Abstract:Treatment reasoning underpins every therapeutic decision, integrating disease context, comorbidities, medications, contraindications, and evolving biomedical knowledge to select an appropriate therapy. It is inherently iterative: candidates are weighed against many constraints, revised as evidence emerges, and grounded in verifiable sources. Here we introduce ATHENA-R1, an AI agent for treatment reasoning across all FDA approved drugs since 1939, trained by reinforcement learning over a universe of 212 biomedical tools. At each step it identifies missing information, selects and runs relevant tools, and incorporates the evidence. To train it without human-annotated traces, we build a two-level self-learning framework: multi-agent systems construct the tools, tasks, and reasoning trajectories for supervised fine-tuning, then reinforcement learning with scientific feedback rewards reasoning quality (evidence gathering, grounded tool use, logical non-redundancy). Across five benchmarks of 3,168 drug reasoning tasks and 456 patient treatment cases, ATHENA-R1 outperforms language models and tool-use systems, reaching 94.7% accuracy on open-ended drug reasoning and 82.9% on treatment reasoning, 17.8 and 10.7 points above GPT-5. In blinded evaluations by experts from 28 rare disease organizations, it is preferred over reference models on all criteria, and physicians rated it favorably on complex hospitalized cardiovascular and infectious-disease cases. Adverse-event hypotheses it generated, tested in electronic health records from 5.4 million patients, reached adjusted odds ratios of 1.48-1.84, with no elevation among negative controls. Because it requires knowing what evidence to seek before concluding, treatment reasoning has long been hard for AI; we show it can be reframed as a learnable process of iterative evidence gathering that reinforcement learning can train AI to perform.

Bibliographic and Citation Tools

Code, Data and Media Associated with this Article

Demos

Recommenders and Search Tools

arXivLabs: experimental projects with community collaborators

arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.

Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.

Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.

© 2026 Now Let Us. All rights reserved.

Source: arXiv cs.AI Recent

Advertisement
Ad slot ready: 5887729102

More in this category

NOW LET US Related – BV-Blend: Uncertainty-Weighted Historical Baselines for Stable Critic-Free RL with Verifiable Rewards

agentic-systems

BV-Blend: Uncertainty-Weighted Historical Baselines for Stable Critic-Free RL with Verifiable Rewards

Researchers have introduced BV-Blend, a critic-free reinforcement learning framework that stabilizes advantage estimation in LLM alignment. By blending historical data with local statistics, BV-Blend overcomes a critical limitation of GRPO-style methods during cold-start training with binary rewards.

NOW LET US Related – Data and Evaluation Closed-Loop for Model Capability Enhancement

agentic-systems

Data and Evaluation Closed-Loop for Model Capability Enhancement

A new study introduces the 'capability slice' to establish a closed loop between evaluation and pre-training data for LLMs. This systematic approach allows engineers to pinpoint model weaknesses and perform targeted data interventions instead of relying on intuition.

NOW LET US Related – Search for Truth from Reasoning: A Dynamic Representation Editing Framework for Steering LLM Trajectories

agentic-systems

Search for Truth from Reasoning: A Dynamic Representation Editing Framework for Steering LLM Trajectories

Researchers have introduced DynaSteer, a dynamic representation editing framework designed to guide Large Language Models (LLMs) toward truthful reasoning trajectories. By dynamically intervening at high-entropy decision points, DynaSteer improves reasoning accuracy without disrupting correct logical paths.

NOW LET US Related – Primary ICD Category Prediction using LLM-based Probing

agentic-systems

Primary ICD Category Prediction using LLM-based Probing

Researchers evaluated whether frozen medical large language model (LLM) representations can serve as a shared embedding space for multimodal primary diagnosis category prediction, achieving high accuracy and efficient cross-dataset transfer.

NOW LET US Related – ComMem: Complementary Memory Systems for Test-Time Adaptation of Vision-Language Models

agentic-systems

ComMem: Complementary Memory Systems for Test-Time Adaptation of Vision-Language Models

Researchers have proposed ComMem, an innovative test-time adaptation (TTA) approach for vision-language models that mimics the complementary memory systems of the biological brain to enhance practical adaptability.

NOW LET US Related – TrajRS: Towards Certified Robustness in Pedestrian Trajectory Prediction

agentic-systems

TrajRS: Towards Certified Robustness in Pedestrian Trajectory Prediction

Researchers have introduced TrajRS, a new framework that enhances and certifies the robustness of pedestrian trajectory prediction models against adversarial attacks, marking a significant step toward safer autonomous driving systems.

EXPLORE TOPICS

Discover All Categories

Deep dive into the specific technology sectors that matter most to you.